Hepatic Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease.

CONCLUSION: In the 32 patients studied, febuxostat was well tolerated in patients with gout and FLD. However, the presence of diabetes and colchicine use may increase the risk of hepatotoxicity.
PMID: 30442825 [PubMed - as supplied by publisher]

Source: J Rheumatol - November 15, 2018 Category: Rheumatology Authors: Lee JS, Won J, Kwon OC, Lee SS, Oh JS, Kim YG, Lee CK, Yoo B, Hong S Tags: J Rheumatol Source Type: research